Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Tax Provisions: 2015-2025

Historic Tax Provisions for ImmunityBio (IBRX) over the last 7 years, with Sep 2025 value amounting to -$35,000.

  • ImmunityBio's Tax Provisions was N/A to -$35,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9,000, marking a year-over-year change of. This contributed to the annual value of -$40,000 for FY2023, which is 217.65% down from last year.
  • Latest data reveals that ImmunityBio reported Tax Provisions of -$35,000 as of Q3 2025, which was down 111.67% from $300,000 recorded in Q2 2025.
  • ImmunityBio's Tax Provisions' 5-year high stood at $300,000 during Q2 2025, with a 5-year trough of -$234,000 in Q1 2025.
  • Its 2-year average for Tax Provisions is -$2,250, with a median of -$37,500 in 2023.
  • Its Tax Provisions has fluctuated over the past 5 years, first spiked by 3,300.00% in 2022, then crashed by 217.65% in 2023.
  • Quarterly analysis of 4 years shows ImmunityBio's Tax Provisions stood at $1,000 in 2021, then skyrocketed by 3,300.00% to $34,000 in 2022, then crashed by 217.65% to -$40,000 in 2023, then reached -$35,000 in 2025.
  • Its Tax Provisions was -$35,000 in Q3 2025, compared to $300,000 in Q2 2025 and -$234,000 in Q1 2025.